ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
The purpose of this study is to evaluate the efficacy and safety of oral valproic acid to slow the progression of visual function and/or to improve the visual function in patients with retinitis pigmentosa (RP). Enrolled subjects in valproic acid group will be treated with oral valproic acid 500mg daily for 48 weeks. Visual function and safety will be assess before and after treatment (48 weeks) between valproic acid and control groups.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa#1114905
- Biomarkers In Retinitis Pigmentosa (BIRP)#881639
- A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)#913103
- Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa#844363
- Modulating the cGMP-dependent pathways to inhibit the progression of retinitis pigmentosa#325366
Record · ID 885760
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive